tradingkey.logo
搜索

Niagen Bioscience Inc

NAGE
添加自选
3.430USD
+0.100+3.00%
收盘 07/02, 13:00美东报价延迟15分钟
273.42M总市值
14.69市盈率 TTM

Niagen Bioscience Inc

3.430
+0.100+3.00%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.00%

5天

+0.29%

1月

-2.00%

6月

-45.12%

今年开始到现在

-46.07%

1年

-73.01%

关键数据
3.350今开
3.445最高
464.71K成交量
14.69市盈率 TTM
10.77市盈率动
--股息TTM
0.58%换手率
3.330昨收
3.350最低
1.12M成交额
31.98市盈率静
3.57市净率
0.00%股息率 TTM
19.05%ROA
14.69052周最高
0.85量比
8.55M净利润
79.71M总股本
0.2335每股收益TTM
2.19Beta
27.07%ROE
4.16052周最低
2.85%振幅
63.47%毛利率
273.42M总市值
-1.60回报/风险
3.03%风险率

TradingKey Niagen Bioscience Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Niagen Bioscience Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名46/387位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价12.60。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Niagen Bioscience Inc评分

相关信息

行业排名
46 / 387
全市场排名
132 / 4565
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Niagen Bioscience Inc亮点

亮点风险
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
业绩高增长
公司营业收入稳步增长,连续3年增长54.87%
估值合理
公司最新PE估值14.69,处于3年历史合理位

分析师目标

根据 5 位分析师
买入
评级
12.600
目标均价
+278.38%
涨幅空间

Niagen Bioscience Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Niagen Bioscience Inc简介

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
公司代码NAGE
公司Niagen Bioscience Inc
CEOFried (Robert N)
网址https://www.niagenbioscience.com/

常见问题

Niagen Bioscience Inc(NAGE)的当前股价是多少?

Niagen Bioscience Inc(NAGE)的当前股价是 3.43。

Niagen Bioscience Inc的股票代码是什么?

Niagen Bioscience Inc的股票代码是NAGE。

Niagen Bioscience Inc股票的52周最高点是多少?

Niagen Bioscience Inc股票的52周最高点是14.69。

Niagen Bioscience Inc股票的52周最低点是多少?

Niagen Bioscience Inc股票的52周最低点是4.16。

Niagen Bioscience Inc的市值是多少?

Niagen Bioscience Inc的市值是273.42M。

现在Niagen Bioscience Inc(NAGE)的股票是买入、持有还是卖出?

根据分析师评级,Niagen Bioscience Inc(NAGE)的总体评级为买入,目标价格为12.60。

Niagen Bioscience Inc(NAGE)股票的每股收益(EPS TTM)是多少

Niagen Bioscience Inc(NAGE)股票的每股收益(EPS TTM)是0.22。